The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The Frequency of Drug-Induced Liver Injury Due to Antibiotics Among Hospitalised Patients
Abstract
Introduction Most epidemiological studies have found antibiotics to be the most common cause of drug-induced liver injury (DILI). It is unclear what the risk of DILI is associated with different antibiotics. Objective The aim of the study was to assess the frequency of DILI due to the most commonly used antibiotics among inpatients, in a population-based setting. Methods Patients who were treated with the 14 most-used antibiotics at Landspitali University Hospital Iceland 2012-2023, with concomitant: > 5 × upper limit of normal (ULN) of alanine aminotransferase (ALT) and/or > 2 × ULN of alkaline phosphatase (ALP), were identified. If DILI was a potential cause, the Revised Electronic Causality Assessment Method (RECAM) method was used to determine likelihood of DILI. Results Overall 2292 patients fulfilled the inclusion criteria, 52 of whom were found to have DILI, median age 67 (range 21-93) years, 58% females, 17 (33%) with jaundice and three (5.8%) died of liver failure. The most commonly implicated agent was amoxicillin/clavulanate (n = 23) in 1:1327 users (0.075%), ceftriaxone (n = 8) 1:3779 (0.02%), cefazolin (n = 7) 1: 6363 (0.016%), cloxacillin 1:6024 (n = 4) (0.017%), piperacillin/tazobactam (n = 2) 1:1551 (0.097%), vancomycin (n = 2) 1:1966 (0.076%), trimethoprim-sulfamethoxazole (TMP/SMX) (n = 3) 1:1096 (0.091%) and ciprofloxacin (n = 1) 1:10,938 (0.009%). In two cases, more than one antibiotic was considered likely. Conclusions Drug-induced liver injury was found…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, among hospitalized patients in Iceland, AC was the most frequent drug associated with DILI (ie, 1 per 1300 patients), while TMP/SMX had the highest overall proportional risk at ~1 per 1000 new prescriptions. 21”
From The contemporary epidemiology, causes, and management of drug-induced liver injury (2026) · cites this paper as [21]
Citations
Cites
Case definition and phenotype standardization in drug-induced liver injury
Aithal, G. P., Watkins, P. B., Andrade, R. J., Larrey, D., Molokhia, M., Takikawa, H., Hunt, C. M., Wilke, R. A., Avigan, M., Kaplowitz, N., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.58 · Cited by 944
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925
Björnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., & Olafsson, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.006 · Cited by 865
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Incidence of drug-induced hepatic injuries: A French population-based study
Sgro, C., Clinard, F., Ouazir, K., Chanay, H., Allard, C., Guilleminet, C., Lenoir, C., Lemoine, A., & Hillon, P. (2002) · Hepatology · doi:10.1053/jhep.2002.34857 · Cited by 716
Outcome and prognostic markers in severe drug‐induced liver disease†
Björnsson, E., & Olsson, R. (2005) · Hepatology · doi:10.1002/hep.20800 · Cited by 524
Self-citationAcute and clinically relevant drug‐induced liver injury: a population based case‐control study
De Abajo, F. J., Montero, D., Madurga, M., & Rodríguez, L. A. G. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02133.x · Cited by 408
Björnsson, E. S., & Hoofnagle, J. H. (2016) · Hepatology · doi:10.1002/hep.28323 · Cited by 245
Self-citationAcute liver failure in Sweden: etiology and outcome
Wei, G., Bergquist, A. M., Broomé, U., Lindgren, S. C., Wallerstedt, S. M., Almer, S. H., Sangfelt, P., Danielsson, A., Sandberg–Gertzén, H., Lööf, L., et al. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01818.x · Cited by 185
Drug‐induced liver injury in a Swedish University hospital out‐patient hepatology clinic
DE VALLE, M. B., AV KLINTEBERG, V., ALEM, N., OLSSON, R., & BJÖRNSSON, E. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03117.x · Cited by 179
Self-citationA revised electronic version of RUCAM for the diagnosis of DILI
Hayashi, P. H., Lucena, M. I., Fontana, R. J., Bjornsson, E. S., Aithal, G. P., Barnhart, H., Gonzalez‐Jimenez, A., Yang, Q., Gu, J., Andrade, R. J., et al. (2022) · Hepatology · doi:10.1002/hep.32327 · Cited by 160
Self-citationComprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
Stephens, C., Robles-Diaz, M., Medina-Caliz, I., Garcia-Cortes, M., Ortega-Alonso, A., Sanabria-Cabrera, J., Gonzalez-Jimenez, A., Alvarez-Alvarez, I., Slim, M., Jimenez-Perez, M., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.029 · Cited by 148
Amoxicillin–Clavulanate-Induced Liver Injury
Drug-Induced Liver Injury Network (DILIN), deLemos, A. S., Ghabril, M., Rockey, D. C., Gu, J., Barnhart, H. X., Fontana, R. J., Kleiner, D. E., & Bonkovsky, H. L. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4121-6 · Cited by 146
Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden
Björnsson, E., Jerlstad, P., Bergqvist, A., & Olsson, R. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510023846 · Cited by 123
Self-citationDevarbhavi, H., Joseph, T., Sunil Kumar, N., Rathi, C., Thomas, V., Prasad Singh, S., Sawant, P., Goel, A., Eapen, C. E., Rai, P., et al. (2021) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2020.11.002 · Cited by 87
Björnsson, E. S., Stephens, C., Atallah, E., Robles‐Diaz, M., Alvarez‐Alvarez, I., Gerbes, A., Weber, S., Stirnimann, G., Kullak‐Ublick, G., Cortez‐Pinto, H., et al. (2023) · Liver International · doi:10.1111/liv.15378 · Cited by 69
Self-citationCabañas, R., Calderón, O. M., Ramírez, E., Fiandor, A. M., Prior, N., Caballero, T., Herranz, P., Bobolea, I. D., López-Serrano, M. C., Quirce, S., et al. (2014) · PubMed · Cited by 63
Identification and Characterization of Cefazolin-Induced Liver Injury
Alqahtani, S. A., Kleiner, D. E., Ghabril, M., Gu, J., Hoofnagle, J. H., & Rockey, D. C. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.036 · Cited by 61
Bessone, F., Hernández, N., Mendizábal, M., Sánchez, A., Paraná, R., Arrese, M. A., Tagle, M., Girala, M., Lizarzábal, M., Carrera, E., et al. (2019) · Clinical Liver Disease · doi:10.1002/cld.778 · Cited by 38
Shin, J., Hunt, C. M., Suzuki, A., Papay, J. I., Beach, K. J., & Cheetham, T. C. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3388 · Cited by 37
Spontaneously Reported Hepatic Adverse Drug Events in Korea: Multicenter Study
Kwon, H. J., Lee, S.-H., Kim, S., Lee, J., Jee, Y., Kang, H., Park, B., Park, J., & Hong, C.-S. (2012) · Journal of Korean Medical Science · doi:10.3346/jkms.2012.27.3.268 · Cited by 36
Kang, Y., Kim, S., Park, S., Park, B. Y., Lee, J., An, J. Y., Won, H., Song, W., Kwon, H., Cho, Y. S., et al. (2020) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2020.12.3.430 · Cited by 35
Rao, A., Rule, J. A., Hameed, B., Ganger, D. R., Fontana, R. J., & Lee, W. M. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001655 · Cited by 33
Pedraza, L., Laosa, O., Rodríguez‐Mañas, L., Gutiérrez-Romero, D. F., Frías, J., Carnicero, J. A. C., & Ramı́rez, E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.600255 · Cited by 25
Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs
Chen, V. L., Rockey, D. C., Bjornsson, E. S., Barnhart, H. X., Hoofnagle, J. H., & for the Drug-Induced Liver Injury Network Investigators (2024) · Drug Safety · doi:10.1007/s40264-024-01486-6 · Cited by 15
Suzuki, A., Tillmann, H. L., Williams, J. S., Hauser, R. G., Frund, J., Suzuki, M., Prior, F., Aithal, G. P., Lucena, M. I., Andrade, R. J., et al. (2022) · Drug Safety · doi:10.1007/s40264-022-01255-3 · Cited by 14
One Dose of Cefazolin — Months of Misery: A Case of Acute Liver Failure With Grave Consequences
Gekhman, D., & Correa, E. (2018) · The American Journal of Gastroenterology · doi:10.14309/00000434-201810001-03038 · Cited by 3
Research works printed but not linked: 2
- https://www.ncbi.nlm.nih.gov/books/NBK547852/
- deLemos AS, Ghabril M, Rockey DC, Gu J, Barnhart H, Fontana RJ, et al. Amoxicillin-clavulanate-induced liver injury. Dig Dis Sci. 2016;61:2406–16. · DOI
Cited by
The contemporary epidemiology, causes, and management of drug-induced liver injury
Swanson, L., & Fontana, R. J. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000001011
Metadata
- Authors
- Björnsson, R. A., Sigurdsson, S. S., Arnarson, D. T., Logason, E., & Björnsson, E. S.
- Venue
- Drug Safety
- Published
- 2025-03-12
- Volume
- 48
- Issue
- 7
- Pages
- 795-804
- ISSN
- 0114-5916
- 1179-1942
- Cited by
- 12
- References
- 27
- Language
- en
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.